Machine Learning

With staggering 34% revenue growth, United Imaging is leveraging R&D and global expansion to disrupt the Western-dominated medical imaging market.

Shanghai's Vivacta Bio raises over $50M from top VCs to revolutionize cancer treatment with its pioneering in vivo CAR-T therapy, GT801.

Italian AI firm ELAI expands to the US, appointing veteran Kjersten Moody to help companies finally get real business results from their AI spend.

A new campaign aims to save a major research hub, igniting a debate over its economic benefits, medical breakthroughs, and the future of animal testing.

A new patent for a biomarker-guided therapy offers hope for millions with treatment-resistant depression and extends market exclusivity for decades.

MindBio's new tech detects intoxication from your voice, promising safer workplaces but sparking major debate over surveillance, bias, and data privacy.

Scottish biotech EnteroBiotix secures major funding to advance its gut therapy for IBS-C, offering new hope for a disease-modifying treatment.

A first-in-class drug, NTX-2001, is now in human trials for alcohol use disorder, offering a new mechanism of action in a field with few options.

HitGen Inc.'s latest sustainability report signals a deep integration of ESG, leveraging its AI-driven R&D platform for both health and environmental gains.

Jozu's 'Awardable' status on the DoD's P1 Marketplace fast-tracks secure AI, promising tamper-proof models for high-stakes military operations.

A record-breaking investment in AI for war ignites a fierce debate over autonomous weapons and the future of global conflict in the age of robots.

A novel topical gel that boosts cellular energy is now in late-stage trials, offering new hope for healing the chronic wounds of diabetic foot ulcers.

How Vietnam's LIHUHU partnered with zMaticoo to grow monetization for its 1.2M users by putting player experience first with advanced AI technology.

A major investment in Finnish tech firm CoreGo signals a new era for live events, promising frictionless payments and AI-driven fan experiences.

Elmo Motion Control's new EASIII software aims to streamline complex motion programming, boosting efficiency and safety in next-generation smart factories.

A global alliance launches a $500M initiative to build the open data foundation for AI to predict biology and revolutionize medicine.

At OCP EMEA 2026, MiTAC showcases new liquid-cooled OCP servers and open-source integrations designed to build more sustainable, high-performance data centers.

A new partnership between Enlitic and Sectra promises to standardize messy imaging data, accelerating AI integration and transforming clinical workflows.

Genomics' big data and Greywolf's novel drugs unite to develop first-in-class treatments for autoimmune diseases, promising a new era of precision medicine.

The company's CEO outlines a bold vision for AI as a utility, while its new Foundation Model aims to scale autonomous driving safety and reliability.